PART I Item 1. Bu siness. We are a clinical stage biotechnology company leveraging evolutionary intelligence to translate tRNA synthetase biology into new therapies for fibrosis and inflammation. tRNA synthetases are ancient, essential proteins that have evolved novel domains that regulate diverse pathways extracellularly in humans. Our discovery platform is focused on unlocking hidden therapeutic intervention points by uncovering signaling pathways driven by our proprietary library of domains d...
Q2 FY2026 — expected 2026-09-14
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-05 | 2025-12-31 | 0001339970-26-000008 | EDGAR | 79K words |
| 2025-03-13 | 2024-12-31 | 0000950170-25-038888 | EDGAR | — |
| 2024-03-14 | 2023-12-31 | 0000950170-24-031584 | EDGAR | — |
| 2023-03-14 | 2022-12-31 | 0000950170-23-007873 | EDGAR | — |
| 2022-03-15 | 2021-12-31 | 0001564590-22-010441 | EDGAR | — |
| 2021-03-24 | 2020-12-31 | 0001564590-21-014940 | EDGAR | — |
| 2020-03-26 | 2019-12-31 | 0001564590-20-013208 | EDGAR | — |
| 2019-03-26 | 2018-12-31 | 0001564590-19-009381 | EDGAR | — |
| 2018-03-20 | 2017-12-31 | 0001564590-18-006333 | EDGAR | — |
| 2017-03-16 | 2016-12-31 | 0001564590-17-004631 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-07 | 2026-06-30 | 0001339970-26-000053 | EDGAR | — |
| 2025-11-06 | 2025-09-30 | 0001193125-25-269587 | EDGAR | 53K words |
| 2025-08-07 | 2025-06-30 | 0001339970-25-000009 | EDGAR | — |
| 2025-05-07 | 2025-03-31 | 0000950170-25-065640 | EDGAR | — |
| 2024-11-07 | 2024-09-30 | 0000950170-24-123305 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0000950170-24-096185 | EDGAR | — |
| 2024-05-02 | 2024-03-31 | 0000950170-24-052092 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0000950170-23-062058 | EDGAR | — |
| 2023-08-09 | 2023-06-30 | 0000950170-23-040598 | EDGAR | — |
| 2023-05-09 | 2023-03-31 | 0000950170-23-019686 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0000950170-22-024724 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0000950170-22-017401 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-07 | 0001339970-26-000051 | EDGAR | — |
| 2026-07-31 | 0001339970-26-000042 | EDGAR | — |
| 2026-03-05 | 0001339970-26-000006 | EDGAR | 3K words |
| 2025-12-05 | 0001193125-25-309619 | EDGAR | — |
| 2025-11-06 | 0001193125-25-269486 | EDGAR | — |
| 2025-09-15 | 0001193125-25-202865 | EDGAR | — |
| 2025-08-07 | 0001339970-25-000007 | EDGAR | — |
| 2025-05-07 | 0000950170-25-065611 | EDGAR | — |
| 2025-05-06 | 0000950170-25-064413 | EDGAR | — |
| 2025-03-13 | 0000950170-25-038703 | EDGAR | — |
224 total filings indexed. 192 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001339970 |
| Ticker | ATYR |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.atyrpharma.com |
| Listed | 2015-05-07 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/ATYR (~200 tokens, structured JSON with cryptographic provenance)